According to a new report published by Allied Market Research, titled, “Skin Barrier Market by Shape and Surgery Type: opportunity analysis and industry forecast, 2018–2026,” The skin barriers market size was valued at $868.1 million in 2018 and is expected to reach $1,191.5 million by 2026, registering a CAGR of 4.1% from 2019 to 2026. Skin barriers are used along with the ostomy pouches, which are used for the management of fecal inconsistency in patients and help them to keep the skin free from contaminants and infections. The skin barrier is a thin film used to close the ostomy bags to prevent the leakage. It is majorly used to avert fecal waste from patient’s body and contain liquid and semiliquid stool. Furthermore, it helps protect patients from exposure, tissue damage, and odor. A skin barrier film is designed to manage fecal inconsistence in bedridden patients, and has proven to be effective even in prevention & infection control. It provides safer patient outcomes and augment ease of nursing. The devices help in attachment of ostomy bags to the individual’s body to maintain incontinence.These skin barriers are available in two different shapes, including flat and convex.
Surge in availability of technological advanced devices for fecal management, rise in geriatric population, and surge in fecal inconsistency related disorders are the major factors driving the market growth of skin barriers market. Furthermore, increase in awareness toward the availability of these devices accompanied with launch of new devices addressing the unmet medical needs significantly contribute toward the market growth. However, lack of trained professionals and patient’s discomfort in using these devices hinder the growth of market. On the contrary, development of the healthcare industry and increase in R&D activities undertaken by key players towards skin barrier functions are expected to boost the market growth during the forecast period.
Depending on shape, the flat-shaped segment dominated the skin barrier market in 2018, and is anticipated to maintain its dominance during the forecast period. This is attributed to increase in usage of flat-shaped skin barriers for the attachment to ostomy pouches in hospitals, clinics, and even home care for management of fecal inconsistence in adults. As the name signifies, flat-shaped skin barriers are flat, which are integrated with beige floating flange. These thin films are used in the ostomy bags to prevent leakage. They are designed to be used with any new drainable, closed, or urostomy pouch with same flange size. These barriers are not made with the natural rubber latex. It is widely used by bedridden patients, elderly people, and individuals suffering from irritable bowel disease.
On the basis of surgery type, the colostomy segment accounted for the majority of skin barrier market share in 2018, and is anticipated to grow at the fastest rate during the forecast period, owing to the fact that these are the most performed surgeries to prevent incontinence. North America accounted for the majority of the market share in 2018, and is anticipated to continue this trend during the forecast period. Ongoing R&D activities for introduction of novel bowel management devices for fecal management is the major trend in the North America skin barriers market. Rise in geriatric population in this region further contributes to the market growth. Asia-Pacific is growing at at a significant CAGR owing to increase in per capita income in many countries, rise in government initiatives for the improvement of the healthcare sector, and surge in focus of leading manufacturers on expanding their geographical presence in emerging Asia-Pacific countries to capture potential growth opportunities in the market. Moreover, rise in demand for these products alarming increase in prevalence of irritable bowel syndrome fuels the skin barrier market growth.
The key players operating in the skin barriers market include 3M Company, B. Braun Melsungen AG, Coloplast Corp, ConvaTec Group PLC, Cymed Ostomy Pouching Systems, Hollister Inc., Marlen Manufacturing & Development Co., Nu-Hope Laboratories, Inc., Safe n’ Simple Medical, and Torbot Group, Inc.
Key Findings Of The Study
By surgery type, the colostomy segment was the highest contributor to the market, with $364.8 million in 2018, and is expected to continue the trend throughout the forecast period.
On the basis of shape, the flat segment is expected to grow at a CAGR of 4.2%.
Region wise, North America was the major shareholder and accounted for the highest share of 36% in 2018.
Asia-Pacific is expected to grow at a CAGR of 4.6% during the forecast period.